The U.S. Food and Drug Administration (FDA) has announced a nationwide thyroid medication Levothyroxine recall on several sodium tablet products because they were found to be subpotent, means contain less active ingredient than stated on the label.
The FDA levothyroxine drug recall involves products packaged and distributed by Major Pharmaceuticals, with some units also distributed by Cardinal Health. While the FDA says the risk of severe health consequences is low, reduced potency could affect treatment outcomes for patients who depend on precise thyroid hormone replacement.
Why Was The Thyroid Medication Levothyroxine Recall Issued?
The thyroid medication Levothyroxine recall was initiated after certain batches of levothyroxine sodium tablets were found to deliver less thyroid hormone than required. This issue, known as subpotency, means the medicine may not work as effectively as intended.
According to the FDA, the recalled products were distributed nationwide beginning in January 2025. However, the agency has not disclosed how many tablets are included in the thyroid medication levothyroxine recall. It was officially initiated on July 13, 2026, and later classified as a Class II FDA recall, indicating the relatively low probability of serious adverse health consequences while acknowledging that treatment may be temporarily compromised.
Which Products Are Included in the FDA Thyroid Medication Recall?
The Levothyroxine sodium tablets recall covers 12 prescription product configurations sold under the Major Pharmaceuticals and Cardinal Health labels.
Affected strengths include:
- 25 mcg
- 50 mcg
- 75 mcg
- 88 mcg
- 112 mcg
- 125 mcg
- 150 mcg
The Levothyroxine recalled products were distributed as:
- Individual 10-tablet blister packs
- Cartons containing 100 tablets (10 blister packs)
The affected lots carry expiration dates ranging from July 2026 through January 2027. Patients are encouraged to review the lot number and expiration date on their medication packaging and compare it with the FDA’s recall notice before taking further action.
What Is the FDA-Recalled Medicine Levothyroxine?
Levothyroxine is a synthetic version of thyroxine (T4), a hormone naturally produced by the thyroid gland. Even small changes in the dose can affect how well thyroid hormone levels are controlled. Because of this, the medication is considered a narrow therapeutic index drug, meaning patients often require highly accurate dosing to maintain normal thyroid function.
The Levothyroxine sodium tablets recall is especially important because the medication is widely prescribed for several thyroid-related conditions, including:
- Hypothyroidism (underactive thyroid)
- Hashimoto’s thyroiditis
- Thyroid cancer treatment
- Goiter (enlarged thyroid gland)
For many patients, levothyroxine is a lifelong medication that replaces the hormone their body can no longer produce naturally. Consistent dosing is essential to maintaining normal metabolism, heart function, energy levels, and overall health.
Who Could Be Most Affected By The FDA Levothyroxine Drug Recall?
Patients who may be particularly vulnerable to reduced medication potency include:
- Individuals who have had their thyroid removed
- Thyroid cancer survivors
- Pregnant women requiring stable thyroid hormone levels
- Children with congenital hypothyroidism
- Patients whose thyroid hormone levels are closely monitored
What Are the Potential Health Risks of Subpotent Thyroid Drugs?
The tablets affected by the thyroid medication Levothyroxine recall are subpotent, so the patients may receive less thyroid hormone than prescribed. Over time, inadequate hormone replacement can reduce treatment effectiveness and allow symptoms of hypothyroidism to return.
Possible symptoms include:
- Fatigue and low energy
- Weight gain
- Increased sensitivity to cold
- Constipation
- Brain fog or difficulty concentrating
- Dry skin
- Slowed heart rate
- Elevated thyroid-stimulating hormone (TSH) levels
The impact may be greater for patients who depend on precise hormone replacement, such as those recovering from thyroid cancer or children with congenital hypothyroidism.
What Should Patients Do If They Have the Recalled Medication?
Health experts stress that patients should not stop taking levothyroxine without consulting their healthcare provider. Abruptly discontinuing thyroid hormone replacement can lead to worsening hypothyroidism and other complications.
Instead, if you have any product from the thyroid medication levothyroxine recall,
- Check the medication’s dosage strength, lot number, and expiration date against the FDA recall notice.
- Contact their pharmacist or prescribing healthcare provider if their medication matches the recalled products.
- Follow pharmacy instructions regarding product returns or replacement.
- Continue taking the medication unless advised otherwise by a healthcare professional.
- Watch for symptoms of consuming subpotent thyroid drugs given above.
- Discuss whether repeat thyroid function testing, including TSH measurements, is appropriate.
